You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Urothelial cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urothelial Carcinoma Trial in United States (Atezolizumab, Bevacizumab)

Terminated
  • Urothelial Carcinoma
  • Phoenix, Arizona
  • +7 more
Dec 15, 2022

Urothelial Carcinoma Trial in Amsterdam (Tremelimumab, Durvalumab, Paclitaxel)

Active, not recruiting
  • Urothelial Carcinoma
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek Ziekenhuis
Jul 7, 2022

Unresectable NSCLC (NSCLC) and Urothelial Cancer Trial in India (Durvalumab)

Recruiting
  • Unresectable Non-small Cell Lung Cancer (NSCLC) and Urothelial Cancer
  • Bangalore, India
  • +10 more
Aug 24, 2022

Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)

Active, not recruiting
  • Solid Tumor
  • Urethral Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 22, 2022

A Genotype-Phenotype Urothelial Cancer Registry

Recruiting
  • Urothelial Cancer
  • +3 more
  • saliva sample and questionaire
  • saliva sample, questionaire
  • Basking Ridge, New Jersey
  • +3 more
Jun 2, 2022

Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation, Locally Advanced Urothelial Carcinoma, Metastatic

Recruiting
  • Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation
  • +3 more
  • Cabozantinib S-malate
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 8, 2022

Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma Trial in Philadelphia (Enfortumab

Not yet recruiting
  • Urothelial Carcinoma
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center - Philadelphia
Jun 27, 2023

Metastatic Urothelial Cancer Trial in China (Enfortumab vedotin)

Active, not recruiting
  • Metastatic Urothelial Cancer
  • Enfortumab vedotin
  • Beijing, China
  • +7 more
Aug 23, 2022

Urothelial Cancer, Metastatic Solid Tumor Trial in New York (Colchicine)

Recruiting
  • Urothelial Cancer
  • Metastatic Solid Tumor
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Mar 5, 2022

Urothelial Cancer, Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Trial in

Recruiting
  • Urothelial Cancer
  • +3 more
  • Sacituzumab Govitecan (SG)
  • Enfortumab vedotin-ejfv (EV)
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Sep 28, 2022

Transitional Cell Cancer of Renal Pelvis and Ureter Trial in New York, Myrtle Beach, Paris (padeliporfin VTP)

Recruiting
  • Transitional Cell Cancer of Renal Pelvis and Ureter
  • padeliporfin VTP
  • Albany, New York
  • +6 more
Jan 3, 2023

Urothelial Cancer Trial in Spain (Nivolumab, Ipilimumab)

Recruiting
  • Urothelial Cancer
  • Huelva, Andalucia, Spain
  • +11 more
Dec 1, 2022

Hydronephrosis, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma,

Active, not recruiting
  • Hydronephrosis
  • +18 more
  • Durvalumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Urothelial/Bladder Cancer, Nos Trial in New York (Atezolizumab, PGV001, Poly ICLC)

Completed
  • Urothelial/Bladder Cancer, Nos
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Mar 7, 2022

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +13 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 8, 2022

Urothelial Cancer of Renal Pelvis, Urothelial Carcinoma of the Renal Pelvis and Ureter, Urothelial Carcinoma Ureter Trial

Available
  • Urothelial Cancer of Renal Pelvis
  • +5 more
  • Mitomycin for pyelocalyceal solution
  • (no location specified)
Aug 5, 2022

Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter Urothelial Carcinoma, Locally Advanced Urethral

Recruiting
  • Locally Advanced Renal Pelvis Urothelial Carcinoma
  • +20 more
  • Duarte, California
  • +16 more
Aug 10, 2022

Urothelial Carcinoma, Urothelial Cancer, Lung Tumors Trial run by the NCI (EP0057, olaparib)

Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

OBSERVATIONAL STUDY OF AVELUMAB AS FIRST-LINE MAINTENANCE

Recruiting
  • Urothelial Cancer
  • Bristol, United Kingdom
  • +9 more
Jan 23, 2023

An Observational Study of Upper Tract Urothelial Cancer

Not yet recruiting
  • Upper Tract Urinary Carcinoma
    • (no location specified)
    Apr 22, 2022

    Renal Pelvis and Ureter Urothelial Carcinoma Trial in Los Angeles (procedure, drug, biological)

    Not yet recruiting
    • Renal Pelvis and Ureter Urothelial Carcinoma
    • Biopsy
    • +5 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Mar 15, 2023

    Non Small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer, Urothelial Carcinoma Trial in Augusta (Cabozantinib,

    Recruiting
    • Non Small Cell Lung Cancer
    • +3 more
    • Augusta, Georgia
      Augusta University Georgia Cancer Center
    Mar 6, 2022

    Urothelial Carcinoma Bladder, Androgen Receptor Positive Trial in Providence (Degarelix, Gemcitabine/Cisplatin)

    Not yet recruiting
    • Urothelial Carcinoma Bladder
    • Androgen Receptor Positive
    • Providence, Rhode Island
      Lifespan Cancer Institute
    May 1, 2023

    Renal Pelvis and Ureter Urothelial Carcinoma Trial in Houston (drug, other, procedure)

    Active, not recruiting
    • Renal Pelvis and Ureter Urothelial Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 21, 2022

    Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma With Glandular

    Recruiting
    • Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 17, 2021